Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Kalow

Showing results (91-100 of 188) with videos related to

Pageof 19
Sort By:
Drug Safety|March 10, 2001
What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?V Ozdemir, N H Shear, W Kalow
Biochemical Pharmacology|April 15, 1972
Effects of halothane and methoxyflurane on rat skeletal muscle mitochondriaB A Britt, W Kalow, L Endrenyi
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1989
Evidence in humans for variant allozymes of the nondeficient sparteine/debrisoquine monooxygenase (P45OIID 1) in vitroR F Tyndale, T Inaba, W Kalow
Nursing Research|May 1, 1987
Re: 'Developmental progress in very low birth weight infants during the first year of life'W Kalow, H W Goedde, D P Agarwal
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1979
Metabolic fate of phenobarbital in man. N-Glucoside formationB K Tang, W Kalow, A A Grey
International Anesthesiology Clinics|January 1, 1979
Epidemiology and inheritance of malignant hyperthermiaW Kalow, B A Britt, F Y Chan
Research Communications in Chemical Pathology and Pharmacology|July 1, 1978
Amobarbital metabolism in man: N-glucoside formationB K Tang, W Kalow, A A Grey
Research Communications in Chemical Pathology and Pharmacology|May 1, 1981
Antipyrine metabolites in two populationsT Inaba, H Uchino, D Kadar, et al.
Clinical Pharmacology and Therapeutics|May 1, 1983
Variability in caffeine metabolismD M Grant, B K Tang, W Kalow
British Journal of Clinical Pharmacology|April 1, 1985
Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and CaucasiansM Jurima, T Inaba, D Kadar, et al.
Pageof 19

Showing results (91-100 of 188) with videos related to

Sort By:
Pageof 19
Drug Safety|March 10, 2001
What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?V Ozdemir, N H Shear, W Kalow
Biochemical Pharmacology|April 15, 1972
Effects of halothane and methoxyflurane on rat skeletal muscle mitochondriaB A Britt, W Kalow, L Endrenyi
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1989
Evidence in humans for variant allozymes of the nondeficient sparteine/debrisoquine monooxygenase (P45OIID 1) in vitroR F Tyndale, T Inaba, W Kalow
Nursing Research|May 1, 1987
Re: 'Developmental progress in very low birth weight infants during the first year of life'W Kalow, H W Goedde, D P Agarwal
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1979
Metabolic fate of phenobarbital in man. N-Glucoside formationB K Tang, W Kalow, A A Grey
International Anesthesiology Clinics|January 1, 1979
Epidemiology and inheritance of malignant hyperthermiaW Kalow, B A Britt, F Y Chan
Research Communications in Chemical Pathology and Pharmacology|July 1, 1978
Amobarbital metabolism in man: N-glucoside formationB K Tang, W Kalow, A A Grey
Research Communications in Chemical Pathology and Pharmacology|May 1, 1981
Antipyrine metabolites in two populationsT Inaba, H Uchino, D Kadar, et al.
Clinical Pharmacology and Therapeutics|May 1, 1983
Variability in caffeine metabolismD M Grant, B K Tang, W Kalow
British Journal of Clinical Pharmacology|April 1, 1985
Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and CaucasiansM Jurima, T Inaba, D Kadar, et al.
Pageof 19